FIVE-YEAR OUTCOMES AFTER LONG-TERM OXANDROLONE ADMINISTRATION IN SEVERELY BURNED CHILDREN
Patrick T. Reeves(Shriners Hospitals for Children - Galveston), Celeste C. Finnerty(The University of Texas Medical Branch at Galveston), Ronald P. Mlcak(Shriners Hospitals for Children - Galveston), Oscar E. Suman(The University of Texas Medical Branch at Galveston), Kristofer Jennings, Jong O. Lee(University of North Carolina at Chapel Hill), Walter J. Meyer(National Institutes of Health), Gordon L. Klein(The University of Texas Medical Branch at Galveston), Jessica Tanksley(The University of Texas Medical Branch at Galveston), Clark R. Andersen(The University of Texas MD Anderson Cancer Center), David N. Herndon(Joseph M. Still Research Foundation), Robert P. Clayton(The University of Texas Medical Branch at Galveston), Nancy N. Crites(The University of Texas Medical Branch at Galveston)
Cited by 56
Related Papers
Genomic responses in mouse models poorly mimic human inflammatory diseases
|Proceedings of the National Academy of Sciences|2013|3k
The leading causes of death after burn injury in a single pediatric burn center
|Critical Care|2009|376
Non-cystic Fibrosis Bronchiectasis
|Unknown|2012|254
Intensive Insulin Therapy in Severely Burned Pediatric Patients: A Prospective Randomized Trial
|American Journal of Respiratory and Critical Care Medicine|2010|210
Longitudinal assessment of Integra in primary burn management: A randomized pediatric clinical trial*
|Critical Care Medicine|2007|185